Simplifying Global Compliance
View Archived Issues
June 18, 2018
Vol. 17
No. 117
Headlines
Full Issue of Drug Industry Daily
View the entire issue. Read More
Hatch Amendment Would Offer Generic Litigants Patent Appeal Choice
Sen. Orrin Hatch (R-Utah) proposes to amend the landmark Hatch-Waxman Act to require generic drugmakers challenging brand patents to choose between inter partes reviews or Hatch-Waxman litigation. Read More
House Passes Bill Cracking Down on Synthetic Opioids
After a flurry of opioid- related bills passed the House earlier last week, the chamber on Friday passed legislation that will limit the availability of synthetic drugs. Read More
Survey Shows U.S. Trust in Pharma Plummets Amid Rising Prices, Opioid Crisis
Americans’ trust in drugmakers plunged in the past year to the lowest level since Edelman launched its annual Trust Barometer survey five years ago. Read More
Montreal Manufacturer Called Out for Cleaning, Testing Issues
The FDA hit Eau Zone Huiles Et Fragrances with a Form 483 after an inspection determined the OTC manufacturer had numerous deficiencies at its Montreal, Quebec facility, including cleaning, testing and drug storage issues. Read More